Charles H Hennekens Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

03/2008	Cyclooxygenase-2 Inhibitors and Most Traditional Nonsteroidal Anti-inflammatory Drugs Cause Similar Moderately Increased Risks of Cardiovascular Disease.
01/2008	The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
11/2007	Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions.
09/2006	Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
01/2006	Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
09/2005	Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding.
07/2005	Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
03/2005	A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
11/2004	Use of aspirin to reduce risks of cardiovascular disease in patients with diabetes: clinical and research challenges.
10/2004	Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis.
07/2004	Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease.
07/2004	Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials.
03/2004	Hypothesis: atorvastatin has pleiotropic effects that translate into early clinical benefits on cardiovascular disease.
01/2004	Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
01/2004	The role of aspirin in cardiovascular diseases--forgotten benefits?
09/2003	An update on aspirin in the primary prevention of cardiovascular disease.
12/2002	Update on aspirin in the treatment and prevention of cardiovascular disease.
04/2002	Use of statins and aspirin to reduce risks of cardiovascular disease.

Articles by Research Topic

Disease

18	Cardiovascular Diseases (Cardiovascular Disease) 03/2008 - 04/2002
6	Stroke (Strokes) 01/2007 - 01/2003
2	Heart Failure 06/2006 - 05/2005
2	Syndrome 05/2006 - 09/2004
2	Neoplasms (Cancer) 07/2005 - 07/2005
2	Hypertension (High Blood Pressure) 04/2004 - 01/2004
2	Myocardial Infarction 09/2003 - 04/2002
2	Atherosclerosis (Atheroma) 03/2003 - 02/2003
2	Coronary Disease (Coronary Heart Disease) 10/2002 - 10/2002
1	Macular Degeneration (Age-Related Maculopathy) 03/2007
1	Asthma (Bronchial Asthma) 01/2007
1	Hemorrhage 09/2005
1	Rheumatoid Arthritis 10/2004
1	Septic Shock (Toxic Shock Syndrome) 09/2004
1	Cataract (Cataracts) 03/2003
1	Cardiomyopathies (Cardiomyopathy) 11/2002

Drug/Important Bio-Agent (IBA)

17	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2008 - 04/2002
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2008 - 10/2004
2	beta Carotene (Betacarotene)FDA Link 03/2007 - 03/2003
2	Vitamin E FDA Link 07/2005 - 07/2004
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2004 - 11/2002
2	Cholesterol Ester Transfer ProteinsIBA 02/2003 - 04/2002
1	PAR-1 ReceptorIBA 01/2007
1	clopidogrel (Plavix)FDA LinkGeneric 12/2006
1	AngiotensinsIBA 06/2006
1	Thrombin Receptors (Thrombin Receptor)IBA 05/2006
1	Phenylpropanolamine (Dexatrim)FDA Link 01/2006
1	Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2005
1	candesartanIBA 05/2005
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2004
1	Aggrenox FDA Link 09/2004
1	HomocysteineIBA 07/2004
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)FDA Link 04/2004
1	atorvastatin (Lipitor)FDA Link 03/2004
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2004
1	Fibrinogen (Factor I)IBA 03/2003
1	Fish OilsIBA 01/2003
1	CholesterolIBA 10/2002
1	LipidsIBA 10/2002
1	ThiazolidinedionesIBA 10/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2004